1. Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist 177Lu‐DOTAGA‐PEG2‐RM26. Issue 12 (23rd May 2019) Authors: Mitran, Bogdan; Rinne, Sara S.; Konijnenberg, Mark W.; Maina, Theodosia; Nock, Berthold A.; Altai, Mohamed; Vorobyeva, Anzhelika; Larhed, Mats; Tolmachev, Vladimir; de Jong, Marion; Rosenström, Ulrika; Orlova, Anna Journal: International journal of cancer Issue: Volume 145:Issue 12(2019) Page Start: 3347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗